-
-
Call more information
660-596-2224 -
Author: Vishal Uppal, MBBS, MSc, FRCA ASA Monitor May 2024, Vol. 88, 1–9. When compared with general anesthesia (GA), patients undergoing surgery solely under peripheral nerve blocks (PNBs) are more likely to have improved short-term postoperative pain control, less nausea and vomiting, early discharge from the postanesthesia care unit and hospital, and overall improved patient satisfaction […]
Read MoreAuthor: David P. Martin, MD, PhD, FASA ASA Monitor May 2024, Vol. 88, 7–8. The largest group of committees and editorial boards within ASA resides in the Division of Scientific Affairs, comprising the sections on Publications, Clinical Care, Subspecialties, Education and Research, and the Annual Meeting. Last year in this column, space allowed us to review […]
Read MoreASA Monitor May 2024, Vol. 88, 27. The U.S. Food and Drug Administration (FDA) has granted approval to Thirona’s LungQ™ AI-based clinical software, making it one of few FDA-cleared solutions able to automatically segment pulmonary structures, aiding in lung diagnosis and documentation. LungQ’s analysis improves the understanding of lung anatomy, facilitating minimally invasive treatments for diseases […]
Read MoreAuthors: George Tewfik, MD, MBA, FASA et al ASA Monitor May 2024, Vol. 88, 1–6. Postoperative cognitive dysfunction (POCD) – also referred to as perioperative neurocognitive disorders – and delirium are pathologic states that may develop after surgery and often result in distress to the patient, family members, medical practitioners, and the health care system. Patients […]
Read MoreASA Monitor May 2024, Vol. 88, 27. A 16-week clinical trial conducted by the National Institutes of Health (NIH) showcased promising results for the monoclonal antibody, omalizumab, in reducing allergic reactions to multiple foods among children ages 1 year and older with food allergies. The trial revealed that nearly 67% of participants who underwent omalizumab treatment […]
Read MoreAuthors: Christopher Fadumiye, MD, FASA et al ASA Monitor June 2024, Vol. 88, 30. Implementation of curricula is constantly evolving, supporting improvements in the quality of medical education and clinical practice (Eur J Anaesthesiol 2019;36:473-6). Evolution within medical education in anesthesiology reflects many factors, including changes in the health care environment and the role of the physician, […]
Read MoreAuthors: Debnath Chatterjee, MD, FAAP, FASA; Viviane Nasr, MD, MPH, FASA ASA Monitor May 2024, Vol. 88, 22–23. Perioperative risk stratification is an integral part of informed consent and medical decision-making processes. It also guides resource allocation and appropriate escalation of care, such as transfer to intensive care settings or tertiary-care hospitals. Fortunately, the incidence of perioperative […]
Read MoreAuthors: Douglas A. Colquhoun, M.B.Ch.B., M.Sc., M.P.H. et al Anesthesiology Newly Published on April 2024. “Despite these limitations, this study still calls attention to the importance of preserving access to routine propofol use in patients undergoing screening and surveillance colonoscopy.” In this month’s issue of the Journal, Quaye et al. report findings of their investigation into […]
Read MoreAuthors: Mohamed A. Ibrahim, MD, PhD, MBA, FASA; Pamela Flood, MD, MA ASA Monitor May 2024, Vol. 88, 20–21. This edition of the ASA Monitor is focused on 30-day postoperative mortality. A search for “30-day mortality” and “obstetrics” on PubMed returns no results! Perhaps women don’t die after labor and delivery. However, the publication of more than 52,000 articles […]
Read MoreAuthor: Randall M. Clark, MD, FASA ASA Monitor May 2024, Vol. 88, 14. Early in 2023, my colleagues from the Colorado Society of Anesthesiologists and I were sitting in Governor Jared Polis’ office in the state capitol. The governor’s office had notified us of his intention to extend to the entire state the limited 2010 rural […]
Read More